HMGU_Icon_Diabetes_2

Featured Publication, Diabetes, HI-MAG,

New "Cool-Down" Hormone Found: Vaspin Slows the Body’s Heat-Producing Fat

A research team at Helmholtz Munich has uncovered a previously unknown “cool-down” signal within body fat. Led by PD Dr. John Heiker and Inka Rapöhn from the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) at Helmholtz…

Portrait Ele Zeggini

Awards & Grants, Computational Health, ITG,

Eleftheria Zeggini Appointed to ERC Scientific Council

The European Commission has appointed Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at Helmholtz Munich, to the Scientific Council of the European Research Council (ERC). Alongside five newly selected members, she will…

Portrait Jian Cui

Awards & Grants, Pioneer Campus,

Jian Cui Wins Prestigious ERC Consolidator Grant

Dr. Jian Cui, principal investigator at the Helmholtz Pioneer Campus, has been awarded an ERC Consolidator Grant for his project PhotonSignaling. As part of Helmholtz Munich’s innovation hub, Cui belongs to a generation of “Pioneers” turning bold…

Blood flow

Awards & Grants, Environmental Health, LHI, Molecular Targets and Therapeutics, MCD,

Funding for Cell Death Research Extended

Research into a novel form of cell death is entering its next phase and could soon help reduce complications after heart attacks or organ transplants. The Federal Ministry of Research, Technology, and Space (BMFTR) is providing continued support for…

Raffaele Teperino

Awards & Grants, Diabetes,

PRO-SCIENTIA Award for Raffaele Teperino

Dr. Raffaele Teperino, Principal Investigator of the Environmental Epigenetics Group at Helmholtz Munich, has been honored with the PRO-SCIENTIA Award 2025 of the Eckhart-Buddecke Foundation. The award, endowed with 10,000 euros, recognizes…

HMGU_Icon_Computat_Health

Featured Publication, Computational Health, ITG,

Tracking Metabolic Clues Years Before Type 2 Diabetes Develops

Researchers at Helmholtz Munich have found that the body begins signaling the risk of type 2 diabetes many years before the disease is diagnosed. In a long-term study, the team examined hundreds of blood metabolites – small molecules that reflect…

Neural Cells Interaction

New Research Findings, Molecular Targets and Therapeutics, MCD,

Single Enzyme Failure Found to Drive Neuron Loss in Dementia

Researchers at Helmholtz Munich, the Technical University of Munich and the LMU University Hospital Munich uncovered a mechanism that protects nerve cells from premature cell death, known as ferroptosis. The study provides the first molecular…

Distribution of proteins in cells

AI, New Research Findings, Diabetes, IDO,

C-COMPASS: AI-Based Software Maps Proteins and Lipids Within Cells

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial proteomics and lipidomics easier to use – no coding required. C-COMPASS allows scientists to profile where proteins and…

Verleihung des Bayerischen Maximiliansordens

Awards & Grants, Stem Cells, IES,

Maria-Elena Torres-Padilla Honored With the Maximiliansorden

Prof. Maria-Elena Torres-Padilla, this year’s Leibniz Prize winner, has received the Bavarian Maximiliansorden for Science and Art. Minister-President Dr. Markus Söder presented the distinguished state honor to her at the State Chancellery,…

STV Technology of EDGE Project

Awards & Grants, Stem Cells, IDG, ISF,

Funding Project Brings New Technology for Precise Therapeutic Delivery Closer to Clinical Application

According to the World Health Organization, around 300 million people worldwide suffer from genetic disorders – and for most of them, no effective treatments exist. A research team at the Institute of Stem Cell Research at Helmholtz Munich is…

Osteoarthritis in knee

Awards & Grants, Computational Health, ICB, ITG, IML,

Helmholtz Munich Launches Pioneering Osteoarthritis Research Project With EU Partners

Helmholtz Munich is part of the EU research initiative PROBE, which aims to fundamentally transform the way osteoarthritis is diagnosed and treated. The project is funded through HORIZON EUROPE by the Innovative Health Initiative and has a total…

Talent Forum Welcome

Events, Stem Cells, IES,

A Platform for Emerging Talent: The Helmholtz Munich Talent Forum 2025

The Helmholtz Munich Talent Forum took place on November 18–19, 2025, at the Helmholtz Munich Conference Center, bringing together eight outstanding early-career scientists from around the world working in the fields of Epigenetics and Nucleic Acids…

Eric Wenzel Übergabe Jürgen Biercher-Preis_1

Awards & Grants, Diabetes, HI-MAG,

Eric Wenzel Receives the 2025 Jürgen-Bierich Research Award

Dr. Eric Wenzel, Clinician Scientist at the Leipzig University and the Helmholtz Institute for Metabolism, Obesity, and Vascular Research (HI-MAG) of Helmholtz Munich and the Medical Faculty of Leipzig University, has been awarded the Jürgen-Bierich…

AI models in science

AI, Awards & Grants, Computational Health, ICB,

Helmholtz Munich to Advance AI Benchmarking With Three Newly Funded Projects

Helmholtz Munich has secured funding in the Helmholtz Association’s first-ever “UNLOCK” call for AI benchmarking. With three projects approved, the center plays a key role in developing high-quality, multimodal benchmarking datasets that will improve…

Futuristic medical concept with red human lungs

Events, Environmental Health, LHI,

ERS–COPD-iNET: International Research Symposium Highlights Opportunities for Early Intervention in COPD

The European Respiratory Society (ERS) and COPD-iNET Research Symposium in Prague brought together more than 120 clinicians, researchers, and patient advocates to address one of the most pressing challenges in respiratory medicine: Chronic…

COPD Lung Day 2025

Environmental Health, LHI,

World COPD Day 2025

World COPD Day aims to raise awareness, share knowledge, and promote action to reduce the global burden of chronic obstructive pulmonary disease (COPD). Helmholtz Munich is driving progress in these efforts, with pioneering research on new…

HI-MAG in 3Sat Nano Documentary: Update on Metabolism: What Pushes our Energy?

The TV channel 3Sat visited our Metabolic Chambers as a part of their latest documentary on metabolic health in which they explore how the brain and hormones make human metabolism highly individual. Watch it here! (German only)

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, SAT,

Fine-Tuning Immunity: The Role of Ubiquitination in T cell Activation

A new study reveals how two key molecular players – the linear ubiquitin chain assembly complex (LUBAC) and TRAF6 – work together to fine-tune immune signaling in T cells. Published in Nature Communications, the research from the group of Prof.…

corona virus 2019-ncov flu outbreak, covid-19 3d banner illustration, microscopic view of floating influenza virus cells

Environmental Health, EPI,

Nako Becomes a Key Pillar of the National Decade on "Post-Infectious Diseases”

NAKO, the German National Cohort, will play a key role in the National Decade on "Post-Infectious Diseases", initiated by the German Federal Ministry of Research, Technology, and Space (BMFTR). Building on its years of foundational work, NAKO…

Woman checking blood sugar level

Events, Diabetes,

World Diabetes Day 2025

Diabetes affects millions worldwide, but research is opening new paths for better prevention, treatment, and ultimately, a cure. Helmholtz Munich is at the forefront of these efforts, advancing science to combat diabetes and related metabolic…

Woman's hands checking diabetes and hyperglycemia with digital blood sugar meter.

New Research Findings, Diabetes, IDM,

One-Hour Blood Glucose Level: A Better Chance to Prevent Diabetes

An elevated blood glucose level one hour after the oral glucose tolerance test (OGTT) signals a critical metabolic state – even before prediabetes. Affected individuals respond particularly well to lifestyle interventions. This value could become a…

Bild Studie POInT

New Research Findings, Diabetes, IDF,

New Milestone Towards Personalized Prevention of Type 1 Diabetes

First results of the Primary Oral Insulin Trial (POInT) mark an important step towards the prevention of type 1 diabetes, pointing future efforts to personalized strategies. The group led by researchers from Helmholtz Munich and the Technical…

HMGU_Icon_Computat_Health

Featured Publication, Computational Health, Health AI,

TITAN: A Multimodal AI Model for Digital Pathology Slides

Scientists at Helmholtz Munich, together with Harvard Medical School and international collaborators, have developed TITAN, an artificial intelligence (AI) model capable of analyzing and describing digital pathology slides. By combining information…

NMR spectroscopy techniques

Events, Molecular Targets and Therapeutics, STB,

Biomolecular Breathing and the 4D View of Life: Insights from the BNMRZ Symposium

How do biomolecules breathe? This question guided the recent international symposium “Ultra-Highfield NMR and 4D Structural Biology – From Mechanisms to Therapies”, hosted by the Bavarian NMR Center (BNMRZ), a joint infrastructure of Helmholtz Munich…

HMGU_Icon_Environm_Health

Featured Publication, Environmental Health, LHI,

How Lung Cells Initiate the Immune Response to Nanoparticles

When nanoparticles enter the lungs, the immune system reacts within minutes. Researchers from the Institute of Lung Health and Immunity (LHI) at Helmholtz Munich have now revealed how alveolar macrophages – immune cells located in the lung’s air sacs…

Schwangere Frau mit Ultraschallbildern

New Research Findings, Diabetes, IDF,

Maternal Type 1 Diabetes May Protect Children Through Epigenetic Changes

Children with a family history of type 1 diabetes (T1D) have an increased risk of developing the disease. However, children born to mothers with T1D are less likely to develop the disease than those whose fathers or siblings have T1D. A new study…

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, MCD,

Triggering Cell Death in Metastatic Melanoma and Lung Adenocarcinoma May Pave the Way for New Cancer Treatments

Two new studies published in Nature show that metastatic melanoma and lung adenocarcinoma rely on the protein ferroptosis suppressor protein 1 (FSP1) for survival – identifying a metabolic dependency that may inform the development of new cancer…

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, STB,

New Switch for Natural Cell Death Identified

In the fight against disease, programmed cell death – also known as apoptosis – is a key protective function of the body. It breaks down cells that are damaged or have undergone dangerous changes. However, cancer cells often manage to override this…

HMGU_Icon_Diabetes_2

Featured Publication, Diabetes, IDR,

Comparing Pancreas Development Across Species to Advance Translational Research and Diabetes Therapies

Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team headed by Helmholtz Munich and the German Center for Diabetes Research (DZD) has now produced a comprehensive evolutionary…

HMGU_Icon_Diabetes_2

Featured Publication, Diabetes, HI-MAG,

Salivary Extracellular Vesicle-Derived microRNAs Are Linked to Obesity, Taste, and Eating Behavior

A research team at the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), an institute from Helmholtz Munich at the University of Leipzig and the University of Leipzig Medical Center, has identified that microRNAs derived from…